2020 ISAR Global Research Project
Define Responders and Non-Responders to Biologics and Describe Their Characteristics Overall and Per Biologic (BEAM)
- To classify responders to biologic treatment by clinical and functional endpoints and describe their characteristics overall and per biologic drug class.
- To operationally assess response to biologic therapy by clinical and functional endpoints including exacerbations, systemic corticosteroids, asthma control and lung function.
- To describe and compare baseline (pre-therapy) demographic, clinical and functional characteristics of response and non-response groups to overall biologic treatment and by biologic class.
Dr. Luis Perez-de-Llano (Spain)